Pyrazoloacridine (PD 115934) is a dual topoisomerase I/II inhibitor with an IC50 of 1.25 µM in K562 cells. This nucleic acid-binding agent exhibits anticancer activity and has been investigated in both in vitro cytotoxicity assays and in vivo preclinical tumor models.
Molecular Weight:
367.4
Purity:
99.72% (May vary between batches)
CAS Number:
[99009-20-8]
Formula:
C19H21N5O3
Target:
Topoisomerase,Apoptosis
Application Notes:
Solubility: DMSO:5.22 mg/mL (14.21 mM)
* VAT and and shipping costs not included. Errors and price changes excepted